R&D

Breaking News | Drug Discovery | Industry News | R&D

Ono Pharmaceutical to Acquire Deciphera for $2.4B

Will enable ONO to build a robust presence in oncology, one of its key priority areas.

04.29.24

Breaking News | Collaborations & Alliances | R&D

Modalis Joins the Ginkgo Technology Network

Grants Ginkgo’s customers access to Modalis’ proprietary epigenome modulation technology, CRISPR-GNDM.

04.12.24

Breaking News | R&D

Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research

Aim to catalyze the discovery of new biomarkers and validate therapeutic approaches previously inaccessible to rare cancer patients.

04.04.24

Breaking News | Clinical Trials | R&D

WCG Launches New Application on Its ClinSphere Technology Platform

New solution is designed to alleviate the burdens faced by sites and investigators in the assessment process.

04.04.24

Why Sofgen Pharmaceuticals?

Integrated services in development, scale up, commercial manufacturing and packaging.

04.04.24

Bio News | Breaking News | Collaborations & Alliances | R&D

BostonGene Named Akoya Biosciences' Qualified CRO

Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.

03.20.24

Breaking News | R&D

Parexel Announces CEO Transition

Jamie Macdonald will retire and transition his role as CEO to the company’s COO and Growth Officer Peyton Howell.

03.18.24

Breaking News | Promotions & Moves | R&D

CRS Clinical Research Services Appoints Dr. Elisabeth Lackner as CEO

Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.

03.15.24

R&D | Scale-up/Technology Transfer

Novel Therapeutic Manufacturing Trends

This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.

03.04.24

Breaking News | Drug Development | Industry News | R&D

CoreRx to Acquire Societal CDMO in $130M Deal

Will create an enhanced CDMO with broad capabilities spanning early-stage formulation development through commercial manufacturing and packaging.

02.29.24

Breaking News | Collaborations & Alliances | R&D

Viatris and Idorsia Enter R&D Collaboration

Viatris to receive exclusive global development & commercialization rights to 2 Phase 3 assets as well as the potential to add additional assets in the future.

02.28.24

Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | R&D

Medidata and Thermo Fisher’s PPD Research Business Renew Relationship

Aim to complete studies faster, boost drug development productivity, and bring treatments to patients sooner.

02.28.24

Breaking News | Drug Discovery | Promotions & Moves | R&D

LenioBio Names New CTO and CCO

Welcomes Kathrin Knauf as Chief Technology Officer and Malene Linderoth as Chief Commercial Officer.

02.22.24

Bio News | Breaking News | Drug Development | Drug Discovery | R&D

AbbVie & Tentarix Partner on Conditionally-Active Biologics for Oncology & Immunology

Will integrate AbbVie's expertise in oncology and immunology with Tentarix's proprietary Tentacles platform.

02.22.24

Breaking News | R&D

Introducing Alys Pharmaceuticals: A New Immuno-Dermatology Focused Company

Boasts a pipeline of programs and platforms targeting multiple dermatological indications.

02.13.24

Breaking News | Preclinical Outsourcing | Promotions & Moves | R&D

StageBio Names David Bruning as CEO

Bruning brings over 25 years of leadership experience within product-based and preclinical testing services companies.

02.12.24

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | R&D

Orexo AB Advances Exploratory Feasibility Study with Sobi

Aims to evaluate if the AmorphOX drug delivery platform can add unique properties to one of Sobi's biomolecules.

02.12.24

Breaking News | Clinical Trials | Collaborations & Alliances | R&D

Saama Expands Collaboration with Pfizer to Expedite Clinical Research

Will leverage cutting-edge, AI-based technologies across Pfizer’s R&D portfolio.

02.12.24

Bioanalytical Services | Breaking News | CRO News | R&D

Celerion Obtains CLIA Certification for Its Bioanalytical Lab

Enables the company to expand its capabilities in clinical trials and diagnostic testing.

02.06.24

Bioanalytical Services | Bioassay Development | Breaking News | R&D

Frontage Taps Henry Gao as Chief Financial Officer

Gao has more than 25 years of experience in leading various functions including finance, audit, investment, project management, compliance and board office.

02.01.24